CBG: The cannabinoid researchers are watching in 2026

CBG: The Cannabinoid Researchers Are Watching Closely in 2026

New Human Studies Reveal Why Cannabigerol (CBG) May Be the Most Versatile Cannabinoid Yet

Quick Summary

For years, CBD dominated the wellness conversation. Now researchers are turning their attention to another cannabinoid that may offer unique benefits for stress, mood, inflammation, metabolic health, and gut support: Cannabigerol (CBG).

Often called the “mother cannabinoid,” CBG is the precursor from which many other cannabinoids are produced in the cannabis plant. While CBD research is decades ahead, a wave of new peer-reviewed studies published in 2024 and 2025 suggests CBG may influence multiple biological systems without causing intoxication.

Most importantly, researchers have now completed some of the first placebo-controlled human trials evaluating CBG directly.

The results are creating excitement throughout the cannabinoid research community.

What Makes CBG Different?

Unlike THC, CBG is non-intoxicating.

Unlike CBD, CBG appears to interact more strongly with certain receptors involved in mood regulation, inflammation, gastrointestinal function, and metabolic signaling.

Researchers have identified activity involving:

• CB1 and CB2 receptors
• Alpha-2 adrenergic receptors
• Serotonin receptors
• TRPV and TRPM ion channels
• PPAR-gamma pathways involved in metabolism and inflammation

Because it works through multiple mechanisms simultaneously, scientists are investigating CBG across a surprisingly wide range of conditions.

New Human Research: CBG and Anxiety

One of the most significant cannabinoid studies published in recent years was a double-blind, placebo-controlled crossover trial examining the acute effects of CBG on anxiety and stress.

Researchers found that participants receiving 20 mg of CBG reported significantly lower anxiety compared to placebo. Importantly, participants did not experience intoxication, cognitive impairment, or motor impairment. Memory performance was also preserved. (Nature)

This study represents one of the first controlled human trials demonstrating measurable psychological benefits from isolated CBG.

Why This Matters

Many wellness consumers are searching for support during the day without feeling sedated.

The emerging evidence suggests CBG may support:

• Stress resilience
• Daytime calm
• Mental clarity
• Emotional balance

without the intoxicating effects associated with THC. (Nature)

CBG and Sleep: Promising but Still Early

Sleep remains one of the most common reasons people explore cannabinoids.

A 2025 randomized, triple-blind, placebo-controlled trial in veterans evaluated oral CBG for sleep quality and overall well-being.

While both the placebo and CBG groups improved and the primary sleep endpoint did not reach statistical significance, researchers reported a favorable safety profile and concluded further investigation is warranted. (PMC)

What We Can Conclude

Current evidence does not support calling CBG a sleep cannabinoid in the same way many people view CBN.

However:

• Safety data continues to look encouraging
• Some participants reported improvements in sleep quality
• Researchers believe additional studies with larger populations are justified

This is an area worth watching over the next few years. (PMC)

Gut Health and Inflammation: One of the Most Exciting Areas

Some of the strongest emerging evidence for CBG involves inflammation and gastrointestinal health.

Recent preclinical research demonstrated that CBG significantly reduced markers of colitis while also influencing the gut microbiome and metabolome in beneficial ways. Researchers observed reduced inflammatory damage and improvements in gut tissue health. (PMC)

Additional studies continue to show anti-inflammatory activity through NF-kB signaling pathways, which play a major role in chronic inflammatory conditions. (PMC)

Why Researchers Are Excited

The gut is increasingly recognized as a central hub affecting:

• Immune function
• Mood
• Metabolism
• Inflammation
• Neurological health

If future human trials confirm these findings, CBG could become one of the most important cannabinoids for supporting whole-body wellness.

Metabolic Health, Blood Sugar, and Weight Management

A growing body of research suggests CBG may influence metabolic function.

Recent reviews have highlighted evidence that CBG may:

• Improve insulin sensitivity
• Reduce inflammatory signaling
• Influence lipid metabolism
• Support healthy glucose regulation

Researchers are now investigating how these mechanisms could potentially affect conditions associated with metabolic dysfunction. (PMC)

While human clinical evidence is still limited, this is one of the fastest-growing areas of cannabinoid research.

Neuroprotection and Brain Health

Several reviews published over the past two years have identified neuroprotection as another promising area for CBG.

Researchers have documented antioxidant and anti-inflammatory actions that may help protect neurons from oxidative stress and inflammatory damage. These mechanisms are attracting interest in neurological research because chronic inflammation is increasingly recognized as a contributor to cognitive decline and neurodegenerative disease. (PMC)

At this stage, most evidence remains preclinical, but the biological rationale is compelling.

What the Research Says About Safety

One encouraging trend across human and preclinical studies is CBG’s safety profile.

Current evidence suggests:

• No intoxicating effects
• Minimal cognitive impairment
• Good tolerability
• Favorable safety findings in controlled trials

However, researchers continue to emphasize that long-term human data remains limited and additional clinical studies are needed. (Nature)

The Bottom Line

CBD may have opened the door, but CBG is rapidly becoming one of the most researched cannabinoids in wellness science.

The strongest evidence currently supports CBG’s potential role in:

✓ Stress and anxiety support

✓ Inflammation regulation

✓ Gut health

✓ Metabolic wellness

✓ Neuroprotective pathways

While more human studies are needed, the first placebo-controlled clinical trials are providing encouraging results and helping move cannabinoid science beyond anecdotal reports.

As research continues to evolve, CBG may emerge as one of the most versatile non-intoxicating cannabinoids available.

The future of cannabinoid wellness may not belong to CBD alone.
It may belong to CBD, CBG, and the powerful synergy created when cannabinoids work together.

References & Peer-Reviewed Research

Human Clinical Studies

1. CBG Reduces Anxiety and Stress in Humans
Lokus, J. et al. (2024). Acute effects of cannabigerol on anxiety, stress, and mood: A placebo-controlled human trial.
Scientific Reports.
https://www.nature.com/articles/s41598-024-66879-0

Key Finding:
Participants receiving CBG reported significantly lower anxiety levels than placebo without intoxication or cognitive impairment.

2. Cannabigerol for Sleep and Well-Being in Veterans
Tervo-Clemmens, B. et al. (2025). A randomized, triple-blind, placebo-controlled study of cannabigerol for sleep disturbances.
https://pmc.ncbi.nlm.nih.gov/articles/PMC12823110/

Key Finding:
CBG demonstrated a favorable safety profile and warrants further investigation for sleep and quality-of-life outcomes.

Gut Health & Inflammation Research

3. Cannabigerol Modulates Gut Inflammation and Microbiome Function
Pagano, E. et al. (2024). Cannabigerol attenuates experimental colitis through modulation of gut microbiota and inflammatory pathways.
https://pmc.ncbi.nlm.nih.gov/articles/PMC11338277/

Key Finding:
Researchers observed reduced inflammatory damage, improved gut barrier function, and favorable microbiome changes.

4. Anti-Inflammatory Mechanisms of Cannabigerol
Borrelli, F. et al. (2025). Cannabigerol and inflammatory signaling pathways: Emerging therapeutic applications.
https://pmc.ncbi.nlm.nih.gov/articles/PMC11764157/

Key Finding:
CBG demonstrated modulation of NF-kB pathways involved in chronic inflammation.

Metabolic Health Research

5. Cannabinoids and Metabolic Dysfunction
Cascio, M.G. et al. (2025). Emerging evidence for cannabinoids in metabolic health and glucose regulation.
https://pmc.ncbi.nlm.nih.gov/articles/PMC11979378/

Key Finding:
CBG may influence insulin sensitivity, lipid metabolism, and inflammatory markers associated with metabolic dysfunction.

Brain Health & Neuroprotection

6. Neuroprotective Potential of Cannabigerol
Gugliandolo, E. et al. (2024). Cannabigerol as a neuroprotective phytocannabinoid: Current evidence and future directions.
https://pmc.ncbi.nlm.nih.gov/articles/PMC11597810/

Key Finding:
CBG demonstrated antioxidant and anti-inflammatory properties that may help protect neurons from oxidative stress.

Comprehensive Reviews

7. Cannabigerol: Pharmacology, Therapeutic Potential and Future Applications
Nachnani, R. et al. (2024). Cannabigerol (CBG): A comprehensive review of pharmacology and therapeutic applications.
https://pmc.ncbi.nlm.nih.gov/articles/PMC10994674/

Key Finding:
CBG exhibits activity across multiple receptor systems involved in mood, inflammation, metabolism, and neurological function.